Pharmally transactions tainted with 'badges of fraud' - Carpio | WHAT REALLY HAPPENED X-Frame-Options: SAMEORIGIN

Pharmally transactions tainted with 'badges of fraud' - Carpio

Retired Supreme Court Senior Associate Justice Antonio Carpio said the transactions of embattled Pharmally Pharmaceutical Corp. with the Procurement Service of the Department of Budget and Management (PS-DBM) have what lawyers call "badges of fraud."

Carpio noted that PS-DBM issued inspection reports of the goods - which were still in China - even without seeing them first.

He said this is falsification of public documents under the Revised Penal Code - "making it appear in a public document that an event or act happened when it did not."

Carpio explained Pharmally is just a "paper corporation," being undercapitalized with a paid-up capital of just only ?625,000.

"No track record - no previous sales to government or private sector; has no factory, has no store, no warehouse, no delivery vehicles, no salesmen, no office (Fort Victoria Tower B in Fort Bonifacio unit vacant since 2018); and no permit to import any pharmaceutical product in 2020, the former magistrate said in a forum organized by opposition coalition 1Sambayan.

Yet, Carpio pointed out that Pharmally bagged negotiated contracts with the government worth ?8.9 billion in just three months in 2020.

"This is a record in the Philippines, if not in the world," he said.